ClinicalTrials.gg
RecruitingNCT05912530Updated Jun 22, 2023

The Influence of Gender on Dual Task Performance in Young Healthy Adults

An observational study in Cognitive Change and Motor Activity, sponsored by Jouf University. Recruiting at 1 site in Saudi Arabia. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-22.

Sponsored by Jouf University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2023, 3 years 2 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
80
Ages
18 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Motor Activity with a site in Saudi Arabia — 2 open to participants now, 2 under way, none of them phase 3. Motor Activity · Saudi Arabia.

Started
2023
with 1 other
Observational
3 of 26
1 open now
Registered
17th of 26
by date
Lead sponsor
1 of 26
Jouf University

Among the 26 studies in Motor Activity with a site in Saudi Arabia, this one is one of 2 that started in 2023, is one of 3 observational ones, and was the 17th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

2 of the 26 studies in Motor Activity with a site in Saudi Arabia are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Saudi Arabia have not opened yet or have stopped. Only those recruiting at a site in Saudi Arabia →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 30 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Motor Activity with a site in Saudi Arabia, or all of them as a file.
02

Study summary

Dual tasking (DT), or the act of conducting multiple, simultaneous tasks, is wide spread in daily life .In particular, the vast majority of mobility tasks we complete (e.g., standing, walking, stepping, etc.) occur while distracted by another motor and/or cognitive task. A common feature of DT is that performance on one or both tasks is diminished when completed together .Understanding the relationship between gender and dual task performance is important because this knowledge could help inform us the development of interventions or training programs that target these differences and improve overall performance. Aims: To investigate the gender-related differences in single task performance through motor torque, cognitive tasks and walking speed, and the combined dual-task costs considering both motor and cognitive performance in a sample of young adults

Read the detailed description

gender differences on dual task performance in young healthy adults. Dual task performance refers to the ability of an individual to perform two tasks simultaneously, which can be a challenging cognitive task because the human brain has a limited capacity for attention and processing. When an individual attempts to perform two tasks at once, they must divide their attention and resources between the two tasks, which can lead to decreased performance and increased errors.

The study will evaluate motor performance, muscle force production, and average speed through a walking test. Sixty non-athlete participants (30 female and 30 male) will be recruited, and ANCOVA will be used for statistical analysis.The participants will perform the following tasks: single mobility tasks (average speed through walking test for 45 seconds), single muscle force production, single cognitive task, dual-task condition: walking test and cognitive task, and dual-task condition: muscle torque test and cognitive task

03

Conditions studied

  • Cognitive Change
  • Motor Activity

Browse trials for

Keywords

  • Gender, Dual task, Cognition, Muscle torque, Speed
04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

healthy ,non athletic, young adult subjects

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 18-30
  • 18-25
  • normal knee range of motion at time of test

Exclusion criteria

Exclusion Criteria:

  • participants had been excluded if they were taking any medications, showed a musculoskeletal injury to the leg, had a cognitive impairment, had a history of surgery, had a cardiovascular condition, or had any other health issue that would have an impact on their physical ability.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • male

    All of the participants were Al jouf University students between the ages of 20 and 35. A BMI between 18 and 30 as well as a normal ROM at the time of the test were inclusion criteria. Additionally, participants had been excluded if they were taking any medications, showed a musculoskeletal injury to the leg, had a cognitive impairment, had a history of surgery, had a cardiovascular condition, or had any other health issue that would have an impact on their physical ability. There was no incentive for the individuals to participate. Prior to data collection, every single participant were informed that being involved in the investigation was voluntary and private, and they provided signed informed consent.

    Other: no intervention

  • female

    All of the participants were Al jouf University students between the ages of 20 and 35. A BMI between 18 and 30 as well as a normal ROM at the time of the test were inclusion criteria. Additionally, participants had been excluded if they were taking any medications, showed a musculoskeletal injury to the leg, had a cognitive impairment, had a history of surgery, had a cardiovascular condition, or had any other health issue that would have an impact on their physical ability. There was no incentive for the individuals to participate. Prior to data collection, every single participant were informed that being involved in the investigation was voluntary and private, and they provided signed informed consent.

    Other: no intervention

Interventions

  • Otherno intervention

    there is no intervention will done

06

What researchers measure

Primary outcomes

  1. Cognition

    a serial subtraction of 3 from a random number between 100 and 150, the duration of each cognitive tasks was measured using a stopwatch of 45s.

    Time frame: 45 seconds

Secondary outcomes

  1. Average speed

    One step app by iphone

    Time frame: 45 seconds

  2. Muscle force production

    The Biodex System 4-Pro Isokinetic Strength Dynamometer was used to quantify muscle torque in the knee extension

    Time frame: 45 seconds

07

Study locations

1 of 1 sites recruiting
  • Jouf University
    Sakaka, Jouf, Saudi Arabia
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — study result

Supporting information: Study protocol, Informed consent form

Time frame: 6 months after publication

Access criteria: Study protocol

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2023; primary completion for Aug 2023, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 12, 2023
First posted
Jun 22, 2023
StartEst.
Jun 30, 2023
Primary completionEst.
Aug 30, 2023
CompletionEst.
Sep 30, 2023
Last update
Jun 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05912530
Lead sponsor
Jouf University
Responsible party
Radwa T. Elshorbagy (assistant professor, Jouf University) — Principal investigator
First posted
Jun 22, 2023
Start date
Jun 30, 2023 (estimated)
Primary completion
Aug 30, 2023 (estimated)
Completion
Sep 30, 2023 (estimated)
Last update
Jun 22, 2023

Study contacts

Radwa Talaat Elshorbagy, Assistant professor
Contact
Rtelshorbagy@ju.edu.sa
00966500920691

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion